NFKBIZ and melanoma: Analysis of therapy-naïve melanoma patients revealed strong IκBζ staining, especially in patients who failed to respond to immunotherapy with nivolumab, either alone or in combination with ipilimumab (CR = complete response, PD = progression disease) (Fig. 5a; Supplementary Fig. S5a).